Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Erfindungs Verwertung

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
Summary

In 1996 was created Erfindungs Verwertung, which is appeared as VC. The company was established in Europe in Switzerland. The main department of described VC is located in the Basel.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. We can highlight the next thriving fund investment areas, such as Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Covalys Biosciences.

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Novartis Venture Fund. In the next rounds fund is usually obtained by Venture Incubator, LLC, Novartis, BVGroup.

The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually.

Read more

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aura Ventures Australia, New South Wales, Sydney
Globalive Communications Canada, Ontario, Toronto
Haima Touzi China, Ningbo Shi, Zhejiang
MCJ Japan, Kasukabe, Saitama Prefecture
Medicash -
New Sustainable Growth Japan, Niigata, Niigata Prefecture
Ogden Pond Group Canada, Halifax, Ontario
One Capital China, Guangdong, Shenzhen
Sumitomo Corporation of America New York, New York, United States
Sustainable Technologies Fund Stockholm, Stockholm County, Sweden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Covalys Biosciences

Biotechnology
$2M01 Feb 2005 Bern, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Erfindungs Verwertung?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: